About Diagnostic BioSystems
Diagnostic BioSystems is a company based in Pleasanton (United States) founded in 1994. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. Diagnostic BioSystems offers products and services including Primary Antibodies, Detection Systems, and Instrumentation. Diagnostic BioSystems operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Pleasanton, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Diagnostic Biosystems Inc.
- Date of Incorporation 31 Jul, 2019
- Jurisdiction Secunderabad, Telangana, India
-
Annual Revenue
$427.4 K (USD)47.69as on Mar 31, 2023
-
Net Profit
-$114.3 K (USD)-4.19as on Mar 31, 2023
-
EBITDA
-$108.92 K (USD)-3.39as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Diagnostic BioSystems
Diagnostic BioSystems offers a comprehensive portfolio of products and services, including Primary Antibodies, Detection Systems, and Instrumentation.
Antibodies are provided for diagnostic tissue analysis.
Systems are designed for accurate pathology detection.
Automated systems are offered for slide staining.
People of Diagnostic BioSystems
Unlock access to complete
Funding Insights of Diagnostic BioSystems
Investors in Diagnostic BioSystems
Diagnostic BioSystems has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Broadoak Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment banking services are offered in the United States.
|
Locked | Locked | Locked |
Investor details for Diagnostic BioSystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diagnostic BioSystems
Investment portfolio details for Diagnostic BioSystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Diagnostic BioSystems
Detailed financials for Diagnostic BioSystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diagnostic Biosystems Comparisons
Peer comparison for Diagnostic BioSystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Diagnostic BioSystems
Diagnostic BioSystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of Diagnostic BioSystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diagnostic Biosystems
Complete news archive for Diagnostic BioSystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diagnostic BioSystems
Diagnostic BioSystems was founded in 1994 and raised its 1st funding round 21 years after it was founded.
Diagnostic BioSystems is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Annual revenue of Diagnostic BioSystems is $427.4K as on Mar 31, 2023.
Diagnostic BioSystems is involved in the development and distribution of innovative anatomic pathology reagents and systems. The company focuses on enhancing immunohistochemistry results for pathology practices. Solutions are offered for diagnostic applications across various markets, including the U.S. and international regions. Products such as primary antibodies, detection systems, and instrumentation are provided to support cancer diagnostics and research. The healthcare sector is primarily served with a commitment to quality and regulatory compliance.
Diagnostic BioSystems's top competitors include Sino Biological, GenScript and Y-Biologics.
Diagnostic BioSystems offers Primary Antibodies, Detection Systems, and Instrumentation.
Diagnostic BioSystems has 1 investor. Key investors include Broadoak Capital Partners.